--- title: "Syra Health Corp. (SYRA.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/SYRA.US.md" symbol: "SYRA.US" name: "Syra Health Corp." industry: "Health Care Services" --- # Syra Health Corp. (SYRA.US) | Item | Detail | |------|--------| | Industry | Health Care Services | | Location | US Market | | Website | [www.syrahealth.com](https://www.syrahealth.com) | ## Company Profile Syra Health Corp., a healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education, and healthcare workforce in the United States. The company offers Syrenity, a behavioral and mental health application that identifies and preven... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-21T04:30:14.000Z **Overall: C (0.50)** **Industry**: Health Care Services | Metric | Value | |--------|-------| | Industry Ranking | 58 / 86 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -3.14% | | | Net Profit YoY | 70.21% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 0.71 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 1.56M | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 7.50M | | **Multi Score**: C #### Profit Score: D | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -45.71% | E | | Profit Margin | -16.89% | D | | Gross Margin | 32.85% | C | #### Growth Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -3.14% | D | | Net Profit YoY | 70.21% | A | | Total Assets YoY | -26.26% | E | | Net Assets YoY | -33.67% | E | #### Cash Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -592.24% | E | | OCF YoY | -3.14% | D | #### Operating Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 1.95 | A | #### Debt Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 32.29% | B | ```chart-data:radar { "title": "Longbridge Financial Score - Syra Health Corp.", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "D", "indicators": [ { "name": "ROE", "value": "-45.71%", "rating": "E" }, { "name": "Profit Margin", "value": "-16.89%", "rating": "D" }, { "name": "Gross Margin", "value": "32.85%", "rating": "C" } ] }, { "name": "Growth", "grade": "D", "indicators": [ { "name": "Revenue YoY", "value": "-3.14%", "rating": "D" }, { "name": "Net Profit YoY", "value": "70.21%", "rating": "A" }, { "name": "Total Assets YoY", "value": "-26.26%", "rating": "E" }, { "name": "Net Assets YoY", "value": "-33.67%", "rating": "E" } ] }, { "name": "Cash", "grade": "D", "indicators": [ { "name": "Cash Flow Margin", "value": "-592.24%", "rating": "E" }, { "name": "OCF YoY", "value": "-3.14%", "rating": "D" } ] }, { "name": "Operating", "grade": "A", "indicators": [ { "name": "Turnover", "value": "1.95", "rating": "A" } ] }, { "name": "Security", "grade": "B", "indicators": [ { "name": "Gearing Ratio", "value": "32.29%", "rating": "B" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | TalkSpace (US.TALK) | C | B | A | A | A | A | | 02 | Cigna (US.CI) | B | B | A | D | B | B | | 03 | BrightSpring Health Services - Unit (US.BTSGU) | C | A | A | D | A | B | | 04 | Labcorp (US.LH) | B | C | B | C | B | B | | 05 | Quest Diagnostics (US.DGX) | B | B | B | C | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -1.24 | 41/79 | - | - | - | | PB | 0.71 | 10/79 | 0.78 | 0.64 | 0.55 | | PS (TTM) | 0.21 | 7/79 | 0.24 | 0.19 | 0.16 | | Dividend Yield | 0.00% | - | - | - | - | ## References - [Company Overview](https://longbridge.com/en/quote/SYRA.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/SYRA.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/SYRA.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.